Skip to main content
Fig. 3 | Journal of Nanobiotechnology

Fig. 3

From: An atherosclerotic plaque-targeted single-chain antibody for MR/NIR-II imaging of atherosclerosis and anti-atherosclerosis therapy

Fig. 3

Evaluation of ASA6 conjugated nanoparticles. A TEM images and size histograms of NaNdF4@NaGdF4 nanoparticles. B TEM images and size histograms of ASA6-NaNdF4@NaGdF4 nanoparticles. C Hydrodynamic size distribution profiles, and zeta potential histogram (D) of NaNdF4@NaGdF4 and ASA6-NaNdF4@NaGdF4 nanoparticles. E Amount of ASA6 conjugated to NaNdF4@NaGdF4 nanoparticles. F Binding capability of ASA6 to target before and after conjugation

Back to article page